Fellah, Slim <br/><br/>
Early evaluation of tumoral response to antiangiogenic therapy by arterial spin labeling perfusion magnetic resonance imaging and susceptibility weighted imaging in a patient with recurrent glioblastoma receiving bevacizumab.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2011 
 - e308-11 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.32.6082  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab<br/>Brain Neoplasms--drug therapy<br/>Camptothecin--administration & dosage<br/>Fatal Outcome<br/>Glioblastoma--drug therapy<br/>Humans<br/>Irinotecan<br/>Magnetic Resonance Angiography<br/>Male<br/>Neoplasm Recurrence, Local--drug therapy<br/>Spin Labels